Aligos Therapeutics, Inc. financial data

Symbol
ALGS on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 527% % 4.8%
Debt-to-equity 78% % 1.4%
Return On Equity -132% % -16%
Return On Assets -74% % -15%
Operating Margin -3307% % -29%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 6,153,507 shares 85%
Entity Public Float $38,700,000 USD 92%
Common Stock, Value, Issued $9,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 10,369,535 shares 65%
Weighted Average Number of Shares Outstanding, Diluted 10,369,535 shares 65%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,623,000 USD -29%
Research and Development Expense $68,445,000 USD -11%
General and Administrative Expense $20,935,000 USD -13%
Operating Income (Loss) $86,734,000 USD 8.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $86,151,000 USD -12%
Income Tax Expense (Benefit) $311,000 USD 14%
Net Income (Loss) Attributable to Parent $86,462,000 USD -12%
Earnings Per Share, Basic -12 USD/shares 59%
Earnings Per Share, Diluted -19 USD/shares 36%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $41,946,000 USD 19%
Cash, Cash Equivalents, and Short-term Investments $99,100,000 USD 32%
Other Assets, Current $4,229,000 USD -12%
Assets, Current $103,435,000 USD 30%
Property, Plant and Equipment, Net $2,035,000 USD -21%
Operating Lease, Right-of-Use Asset $3,581,000 USD -34%
Other Assets, Noncurrent $713,000 USD 12%
Assets $109,764,000 USD 24%
Accounts Payable, Current $4,651,000 USD 70%
Employee-related Liabilities, Current $5,280,000 USD 20%
Accrued Liabilities, Current $13,605,000 USD -3.9%
Liabilities, Current $21,987,000 USD 4.9%
Operating Lease, Liability, Noncurrent $2,380,000 USD -57%
Liabilities $37,931,000 USD -1%
Accumulated Other Comprehensive Income (Loss), Net of Tax $455,000 USD -21%
Retained Earnings (Accumulated Deficit) $622,320,000 USD -16%
Stockholders' Equity Attributable to Parent $71,833,000 USD 43%
Liabilities and Equity $109,764,000 USD 24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $20,909,000 USD 8.1%
Net Cash Provided by (Used in) Financing Activities $101,742,000 USD
Net Cash Provided by (Used in) Investing Activities $44,067,000 USD 50%
Common Stock, Shares Authorized 115,800,000 shares 457%
Common Stock, Shares, Issued 6,153,507 shares 85%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42,056,000 USD 19%
Deferred Tax Assets, Valuation Allowance $56,517,000 USD 65%
Deferred Tax Assets, Gross $58,274,000 USD 59%
Operating Lease, Liability $8,217,000 USD -25%
Depreciation $839,000 USD -35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $86,584,000 USD -13%
Lessee, Operating Lease, Liability, to be Paid $9,052,000 USD -28%
Property, Plant and Equipment, Gross $14,490,000 USD 2.6%
Operating Lease, Liability, Current $3,542,000 USD 4.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,792,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,671,000 USD 3.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 13%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $835,000 USD -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,434,000 USD -62%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $771,000 USD 679%
Lessee, Operating Lease, Liability, to be Paid, Year Four $155,000 USD -89%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,757,000 USD -26%
Share-based Payment Arrangement, Expense $5,292,000 USD -43%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%